# Lithocholic Acid Restores Gut Microbiota and Bile Acid Homeostasis to Improve Type 2 Diabetes

**Authors:** Han Ge, Mengxiao Guo, Xin Chen, Lu Chen, Xin Yang, Dingzuo Ge, Liqiang Guo, Yue Luo, Guangbo Ge, Lei Zhang, Ruirui Wang

PMC · DOI: 10.3390/nu18020341 · 2026-01-21

## TL;DR

Lithocholic acid improves type 2 diabetes by restoring gut bacteria and bile acid balance, which helps regulate blood sugar and insulin.

## Contribution

This study reveals lithocholic acid's novel role in improving diabetes through gut microbiota and bile acid homeostasis.

## Key findings

- Lithocholic acid supplementation reduced fasting glucose and insulin levels in diabetic mice.
- It increased gut A. muciniphila abundance and short-chain fatty acids while improving intestinal barrier markers.
- The compound modulated bile acid metabolism and signaling pathways (TGR5 and FXR) in the ileum.

## Abstract

Background: Bile acids participate in several metabolic processes, and disturbances in their circulating profiles are commonly observed in type 2 diabetes. In a cohort of older adults, individuals with diabetes exhibited markedly lower concentrations of metabolites derived from lithocholic acid. These findings prompted further evaluation of the metabolic effects of lithocholic acid. Methods: We assessed the actions of lithocholic acid in a mouse model of diabetes induced by a high-fat diet and streptozotocin. Fasting glucose, insulin levels, lipid parameters, and measures of insulin resistance were evaluated. Gut microbial composition, short-chain fatty acids, fecal enzyme activities, intestinal barrier markers, and bile acid patterns were analyzed. In vitro assays examined the direct effects of lithocholic acid on A. muciniphila and bile acid metabolism. Results: Lithocholic acid supplementation lowered fasting glucose and insulin levels and improved insulin resistance. It shifted the gut microbial community toward a healthier structure, increased the abundance of A. muciniphila, and raised short-chain fatty acid concentrations. Fecal bile salt hydrolase and β-glucuronidase activity declined, and intestinal barrier markers improved. Lithocholic acid enhanced TGR5 expression and reduced FXR signaling in the ileum. In vitro, physiologically relevant concentrations promoted A. muciniphila growth and altered microbial bile acid metabolism. Conclusions: Lithocholic acid influences the interactions among gut microbes, bile acid pathways, and host metabolic regulation. These findings suggest that this compound may have value as a dietary component that supports metabolic health in type 2 diabetes.

## Linked entities

- **Proteins:** GPBAR1 (G protein-coupled bile acid receptor 1), NR1H4 (nuclear receptor subfamily 1 group H member 4)
- **Chemicals:** lithocholic acid (PubChem CID 9903)
- **Diseases:** type 2 diabetes (MONDO:0005148)

## Full-text entities

- **Diseases:** Type 2 Diabetes (MESH:D003924), insulin resistance (MESH:D007333), diabetes (MESH:D003920)
- **Chemicals:** short-chain fatty acid (MESH:D005232), glucose (MESH:D005947), lipid (MESH:D008055), Lithocholic Acid (MESH:D008095), Bile Acid (MESH:D001647), streptozotocin (MESH:D013311)
- **Species:** Akkermansia muciniphila (species) [taxon 239935], Mus musculus (house mouse, species) [taxon 10090]

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12845021/full.md

---
Source: https://tomesphere.com/paper/PMC12845021